欢迎来到天天文库
浏览记录
ID:18446619
大小:337.17 KB
页数:4页
时间:2018-09-18
《活性维生素d3对透析前慢性肾脏病患者肾脏保护作用研究》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、·620·中国中西医结合肾病杂志2011年7月第12卷第7期CJITWN,July201l,Vo1.12,No.7活性维生素D3对透析前慢性肾脏病患者肾脏保护作用研究:l:祝胜郎①陈结慧①蒋莹①叶玲①朱恒梅①彭伯深①李向阳④[摘要]目的:探讨活性维生素D3对透析前慢性肾脏病(CKD)患者的肾保护作用及安全性。方法:选择透析前3—4期慢性肾脏病患者2oo例,随机分为治疗组和对照组各100例。对照组给予优质低蛋白饮食、eL一酮酸、血管紧张素转换酶抑制剂(ACEI)和(或)血管紧张素Ⅱ受体拮抗剂(ARB)和(或)钙通道拮抗剂以及抗血小板集聚等常规治疗,治疗组在常规治疗的基础上加用骨化三醇(O
2、.5g/d,疗程1年)。分别在治疗前和治疗后3,6,9和12月检测患者肾功能、血清白蛋白、甲状旁腺素、血钙、磷及24h尿蛋白定量等指标,并观察其副作用。结果:两组治疗后3月血肌酐、尿素氮、血尿酸和24h尿蛋白均明显下降(P<0.05),估算肾小球滤过率和血清白蛋白显著上升(P<0.05)。治疗组治疗12月后肾功能进一步改善(P<0.05),尿蛋白进一步减少(P<0.05),而对照组治疗12月后肾功能和尿蛋白与治疗3月相比无明显改变。对照组患者血钙降低,血磷升高,甲状旁腺素水平明显升高(P<0.05)。治疗组患者血钙升高,血磷降低,甲状旁腺索水平明显下降(P3、等副作用。结论:骨化三醇能显著改善透析前CKD患者的肾功能,减少蛋白尿,抑制继发性甲状旁腺素分泌,具有明显的肾脏保护作用,且无明显副作用。[关键词]活性维生素D3慢性肾脏病肾保护RenoprotectiveRoleofActiveVitaminD3inPredialysisPatientswjthChronicKidneyDiseaseZHUSheng~ng,CHENJiehui,JIANGYing,etalDepartmentofNephrology,TheSixthHospitalofShenzhen,Shenzhen(518052)ABSTRACTObjective:Toinve4、stigatetherenoprotectiveeffectandsafetyoforalcalcitriolonpredialysispatientswithchronickidneydisease(CKD).Methods:200CKDstage3and4patientswithsecondaryhyperparathyroidism(SHPT)wererandomizedtoo—ralcalcitriol(n=100)orcontrol(n=100)andfollowedforupto12months.Thecontrolgroupswasgivenconventionalthe5、rapyin-cludinghigh—qualitylow—proteindiet,compound0【一ketoacid,angiotensinconvertingenzymeinhibitor(ACEI)and(or)angio-tensinⅡreceptorblocker(ARB),and(or)calciumchannelantagonists,anti—plateletaggregation,andsoon.Thetreatmentgroupsacceptedcalcitriol(0.5昏/d,foroneyear)onthebasisofconventionaltherap6、y.Thebloodureanitrogen(BUN),serumcreati—nine,8erumuricacid,serumparathyroidhormone,serumcalcium,serumphosphorusandserumalbuminand24hoururinaryproteinweredetectedrespectivelybeforeandafter3,6,9,and12monthsoftherapy,andthesideeffectswereobservedduringthecourseofstudy.Results:Serumcreatinine,BUN,se7、rumuricacidand24hurinaryproteindecreasedobviously,andestimatedomemlarfiltra—tionrate(eGFR)andserumalbuminincreasedsignificantlyinbethcontrolandtreatmentgroupsafter3monthsoftherapy(P<0.05).rI1}lerenalfunctionfurtherimproved(P
3、等副作用。结论:骨化三醇能显著改善透析前CKD患者的肾功能,减少蛋白尿,抑制继发性甲状旁腺素分泌,具有明显的肾脏保护作用,且无明显副作用。[关键词]活性维生素D3慢性肾脏病肾保护RenoprotectiveRoleofActiveVitaminD3inPredialysisPatientswjthChronicKidneyDiseaseZHUSheng~ng,CHENJiehui,JIANGYing,etalDepartmentofNephrology,TheSixthHospitalofShenzhen,Shenzhen(518052)ABSTRACTObjective:Toinve
4、stigatetherenoprotectiveeffectandsafetyoforalcalcitriolonpredialysispatientswithchronickidneydisease(CKD).Methods:200CKDstage3and4patientswithsecondaryhyperparathyroidism(SHPT)wererandomizedtoo—ralcalcitriol(n=100)orcontrol(n=100)andfollowedforupto12months.Thecontrolgroupswasgivenconventionalthe
5、rapyin-cludinghigh—qualitylow—proteindiet,compound0【一ketoacid,angiotensinconvertingenzymeinhibitor(ACEI)and(or)angio-tensinⅡreceptorblocker(ARB),and(or)calciumchannelantagonists,anti—plateletaggregation,andsoon.Thetreatmentgroupsacceptedcalcitriol(0.5昏/d,foroneyear)onthebasisofconventionaltherap
6、y.Thebloodureanitrogen(BUN),serumcreati—nine,8erumuricacid,serumparathyroidhormone,serumcalcium,serumphosphorusandserumalbuminand24hoururinaryproteinweredetectedrespectivelybeforeandafter3,6,9,and12monthsoftherapy,andthesideeffectswereobservedduringthecourseofstudy.Results:Serumcreatinine,BUN,se
7、rumuricacidand24hurinaryproteindecreasedobviously,andestimatedomemlarfiltra—tionrate(eGFR)andserumalbuminincreasedsignificantlyinbethcontrolandtreatmentgroupsafter3monthsoftherapy(P<0.05).rI1}lerenalfunctionfurtherimproved(P
此文档下载收益归作者所有